• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过剖析病历构建卵巢癌转移指数。

Constructing an ovarian cancer metastasis index by dissecting medical records.

作者信息

Qu Yanjun, He Yanan, Li Zhangming, Chen Xiuwei, Liu Qian, Zou Shuangshuang, Kong Congcong, Liu Yixiu, Gao Ce, Zhang Guangmei, Zhu Wenliang

机构信息

Department of Gynecology, The First Affiliated Hospital of Harbin Medical University, Harbin, China.

Department of Pharmacy, Guangdong Hospital of Integrated Chinese and Western Medicine, Foshan, China.

出版信息

Oncotarget. 2017 Nov 6;8(60):102212-102222. doi: 10.18632/oncotarget.22336. eCollection 2017 Nov 24.

DOI:10.18632/oncotarget.22336
PMID:29254237
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5731947/
Abstract

Globally, ovarian cancer (OC) is the leading cause of gynecological cancer-associated deaths. Metastasis, especially multi-organ metastasis, determines the speed of disease progression. A multicenter retrospective study was performed to identify the factors that drive metastasis, from medical records of 534 patients with OC. The average number of target organs per patient was 3.66, indicating multi-organ metastasis. The most common sites of metastasis were large intestine and greater omentum, which were prone to co-metastasis. Results indicated that ascites and laterality, rather than age and menopausal status, were the potential drivers for multi-organ metastasis. Cancer antigen (CA) 125 (CA-125) and nine other blood indicators were found to show a significant, but weak correlation with multi-organ metastasis. A neural network cascade-multiple linear regression hybrid model was built to create an ovarian cancer metastasis index (OCMI) by integration of six multi-organ metastasis drivers including CA-125, blood platelet count, lymphocytes percentage, prealbumin, ascites, and laterality. In an independent set of 267 OC medical records, OCMI showed a moderate correlation with multi-organ metastasis (Spearman ρ = 0.67), the value being 0.72 in premenopausal patients, and good performance in identifying multi-organ metastasis (area under the receiver operating characteristic curve = 0.832), implying a potential prognostic marker for OC.

摘要

在全球范围内,卵巢癌(OC)是妇科癌症相关死亡的主要原因。转移,尤其是多器官转移,决定了疾病进展的速度。我们进行了一项多中心回顾性研究,从534例OC患者的病历中确定驱动转移的因素。每位患者的平均靶器官数量为3.66个,表明存在多器官转移。最常见的转移部位是大肠和大网膜,它们容易发生共同转移。结果表明,腹水和肿瘤侧别而非年龄和绝经状态是多器官转移的潜在驱动因素。发现癌抗原(CA)125(CA-125)和其他九种血液指标与多器官转移呈显著但较弱的相关性。通过整合包括CA-125、血小板计数、淋巴细胞百分比、前白蛋白、腹水和肿瘤侧别在内的六个多器官转移驱动因素,构建了一个神经网络级联-多元线性回归混合模型,以创建卵巢癌转移指数(OCMI)。在一组独立的267份OC病历中,OCMI与多器官转移呈中度相关(Spearman ρ = 0.67),绝经前患者的值为0.72,在识别多器官转移方面表现良好(受试者工作特征曲线下面积 = 0.832),这意味着它可能是OC的一个潜在预后标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8996/5731947/5ef68c1720cc/oncotarget-08-102212-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8996/5731947/e0730d10012a/oncotarget-08-102212-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8996/5731947/3ef756361170/oncotarget-08-102212-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8996/5731947/fac939da0f66/oncotarget-08-102212-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8996/5731947/a3cd7c048ffd/oncotarget-08-102212-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8996/5731947/3262794d2610/oncotarget-08-102212-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8996/5731947/5ef68c1720cc/oncotarget-08-102212-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8996/5731947/e0730d10012a/oncotarget-08-102212-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8996/5731947/3ef756361170/oncotarget-08-102212-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8996/5731947/fac939da0f66/oncotarget-08-102212-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8996/5731947/a3cd7c048ffd/oncotarget-08-102212-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8996/5731947/3262794d2610/oncotarget-08-102212-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8996/5731947/5ef68c1720cc/oncotarget-08-102212-g006.jpg

相似文献

1
Constructing an ovarian cancer metastasis index by dissecting medical records.通过剖析病历构建卵巢癌转移指数。
Oncotarget. 2017 Nov 6;8(60):102212-102222. doi: 10.18632/oncotarget.22336. eCollection 2017 Nov 24.
2
Early identification of recurrence in ovarian cancer: a comparison between the ovarian cancer metastasis index and CA-125 levels.卵巢癌复发的早期识别:卵巢癌转移指数与CA-125水平的比较
PeerJ. 2018 Nov 7;6:e5912. doi: 10.7717/peerj.5912. eCollection 2018.
3
Performance of the IOTA ADNEX model in preoperative discrimination of adnexal masses in a gynecological oncology center.IOTA ADNEX模型在妇科肿瘤中心术前鉴别附件包块中的表现
Ultrasound Obstet Gynecol. 2017 Jun;49(6):778-783. doi: 10.1002/uog.15963. Epub 2017 Apr 12.
4
Significance of preoperative serum CA-125 levels in the prediction of lymph node metastasis in epithelial ovarian cancer.术前血清CA-125水平在上皮性卵巢癌淋巴结转移预测中的意义
Acta Obstet Gynecol Scand. 2008;87(11):1136-42. doi: 10.1080/00016340802478158.
5
Rajavithi-ovarian cancer predictive score (R-OPS): A new scoring system for predicting ovarian malignancy in women presenting with a pelvic mass.拉贾维蒂卵巢癌预测评分(R-OPS):一种用于预测盆腔肿块女性卵巢恶性肿瘤的新评分系统。
Gynecol Oncol. 2016 Jun;141(3):479-484. doi: 10.1016/j.ygyno.2016.03.019. Epub 2016 Mar 22.
6
Diagnostic value of plasma lysophosphatidic acid levels in ovarian cancer patients: A case-control study and updated meta-analysis.血浆溶血磷脂酸水平在卵巢癌患者中的诊断价值:一项病例对照研究及更新的荟萃分析。
J Obstet Gynaecol Res. 2015 Dec;41(12):1951-8. doi: 10.1111/jog.12806. Epub 2015 Oct 16.
7
Preoperative Prediction of Cardiophrenic Lymph Node Metastasis in Advanced Ovarian Cancer Using Computed Tomography.利用计算机断层扫描对晚期卵巢癌中心膈淋巴结转移进行术前预测
Ann Surg Oncol. 2016 Apr;23(4):1302-8. doi: 10.1245/s10434-015-5015-0. Epub 2015 Dec 29.
8
Long-term survival in pseudo-Meigs' syndrome caused by ovarian metastases from colon cancer.结肠癌卵巢转移所致假性梅格斯综合征的长期生存情况
World J Surg Oncol. 2016 Nov 14;14(1):286. doi: 10.1186/s12957-016-1040-0.
9
Approaches to the detection of ovarian cancer.卵巢癌的检测方法。
Scand J Clin Lab Invest Suppl. 2016;245:S49-53. doi: 10.1080/00365513.2016.1208452. Epub 2016 Jul 19.
10
Diagnostic value of HE4 for ovarian cancer: a meta-analysis.HE4 对卵巢癌的诊断价值:一项荟萃分析。
Clin Chem Lab Med. 2012 Feb 3;50(8):1439-46. doi: 10.1515/cclm-2011-0477.

引用本文的文献

1
Mechanomimetic 3D Scaffolds as a Humanized In Vitro Model for Ovarian Cancer.机械模拟 3D 支架作为卵巢癌的人源化体外模型。
Cells. 2022 Feb 26;11(5):824. doi: 10.3390/cells11050824.
2
The Role of Cancer Stem Cells and Mechanical Forces in Ovarian Cancer Metastasis.癌症干细胞和机械力在卵巢癌转移中的作用
Cancers (Basel). 2019 Jul 18;11(7):1008. doi: 10.3390/cancers11071008.
3
Early identification of recurrence in ovarian cancer: a comparison between the ovarian cancer metastasis index and CA-125 levels.卵巢癌复发的早期识别:卵巢癌转移指数与CA-125水平的比较

本文引用的文献

1
Modeling using clinical examination indicators predicts interstitial lung disease among patients with rheumatoid arthritis.使用临床检查指标进行建模可预测类风湿性关节炎患者的间质性肺疾病。
PeerJ. 2017 Feb 21;5:e3021. doi: 10.7717/peerj.3021. eCollection 2017.
2
Cancer Statistics, 2017.《2017 年癌症统计》
CA Cancer J Clin. 2017 Jan;67(1):7-30. doi: 10.3322/caac.21387. Epub 2017 Jan 5.
3
Emerging diagnostic, prognostic and therapeutic biomarkers for ovarian cancer.卵巢癌新出现的诊断、预后和治疗生物标志物。
PeerJ. 2018 Nov 7;6:e5912. doi: 10.7717/peerj.5912. eCollection 2018.
4
Breast cancer identification via modeling of peripherally circulating miRNAs.通过外周循环微小RNA建模进行乳腺癌识别
PeerJ. 2018 Mar 26;6:e4551. doi: 10.7717/peerj.4551. eCollection 2018.
Cell Oncol (Dordr). 2017 Apr;40(2):105-118. doi: 10.1007/s13402-016-0309-1. Epub 2016 Dec 15.
4
Mechanisms and Targets Involved in Dissemination of Ovarian Cancer.卵巢癌播散涉及的机制与靶点
Cancer Genomics Proteomics. 2016;13(6):407-423. doi: 10.21873/cgp.20004.
5
Preoperative multiplication of neutrophil and monocyte counts as a prognostic factor in epithelial ovarian cancer.术前中性粒细胞和单核细胞计数的增加作为上皮性卵巢癌的一个预后因素。
Cancer Biomark. 2016;17(4):419-425. doi: 10.3233/CBM-160658.
6
Redefining the origin and evolution of ovarian cancer: a hormonal connection.重新定义卵巢癌的起源与演变:一种激素关联
Endocr Relat Cancer. 2016 Sep;23(9):R411-22. doi: 10.1530/ERC-16-0209. Epub 2016 Jul 20.
7
Magnetic resonance imaging for distinguishing ovarian clear cell carcinoma from high-grade serous carcinoma.磁共振成像用于鉴别卵巢透明细胞癌与高级别浆液性癌。
J Ovarian Res. 2016 Jul 4;9(1):40. doi: 10.1186/s13048-016-0251-x.
8
Ascites modulates cancer cell behavior, contributing to tumor heterogeneity in ovarian cancer.腹水调节癌细胞行为,导致卵巢癌肿瘤异质性。
Cancer Sci. 2016 Sep;107(9):1173-8. doi: 10.1111/cas.12987. Epub 2016 Aug 16.
9
Neutrophil Granulocytes in Ovarian Cancer - Induction of Epithelial-To-Mesenchymal-Transition and Tumor Cell Migration.卵巢癌中的中性粒细胞——上皮-间质转化及肿瘤细胞迁移的诱导
J Cancer. 2016 Mar 10;7(5):546-54. doi: 10.7150/jca.14169. eCollection 2016.
10
Current clinical application of serum biomarkers to detect ovarian cancer.血清生物标志物在卵巢癌检测中的当前临床应用。
Prz Menopauzalny. 2015 Dec;14(4):254-9. doi: 10.5114/pm.2015.55887. Epub 2015 Nov 27.